German Registry of Alzheimer's Disease Treated With Transcranial Pulse Stimulation — GE-R-A-TPS  

Alzheimer Disease Clinical Trial

Official title: German (GE) Multicenter Prospective Data Collection (Registry) on Treatment With Transcranial Pulse Wave Stimulation (TPS) in Patients With Alzheimer's Disease (A)

Status Not yet recruiting

Clinical Trial Summary

This study will primarily investigate the safety and secondarily the effect and applicability of Transcranial Pulse Wave Stimulation (TPS) for the treatment of Alzheimer's disease in the context of a PMCF study (Post-Market Clinical Follow-up). The multicenter, prospective data collection should help to optimize the stimulation protocol, as well as to record frequent to occasional adverse effects of the product and cognitive, affective and subjective scores.

Clinical Trial Description

This study will primarily investigate the safety and secondarily the effect and applicability of Transcranial Pulse Wave Stimulation (TPS) for the treatment of Alzheimer's disease in the context of a PMCF study (Post-Market Clinical Follow-up). The multicenter, prospective data collection should help to optimize the stimulation protocol, as well as to record frequent to occasional adverse effects of the product and cognitive, affective and subjective scores. Adverse effects and adverse events without a clear causal relationship will be documented in terms of frequency and severity. Furthermore, the progression of improvement in Alzheimer's symptoms as a result of TPS treatment is summarized in various neuropsychological scales. ;

Related Conditions & MeSH terms

• Alzheimer Disease

• NCT number: NCT06313944
• Study type: Observational
• Source: Heinrich-Heine University, Duesseldorf
• Contact: Lars Wojtecki, Prof. Dr.
• Phone: +492118106756
• Email: wojtecki@uni-duesseldorf.de
• Status: Not yet recruiting
• Start date: April 1, 2024
• Completion date: October 1, 2026